Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 866-868, August 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jameson, E.
Right arrow Articles by Ryan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jameson, E.
Right arrow Articles by Ryan, R. M.

The Inhibition by Guinea Pig Serum of the Growth of the Murphy-Sturm Lymphosarcoma*

Eloise Jameson, Herman Ainis{dagger} and R. Mark Ryan

( University of Southern California, Department of Medicine, Los Angeles, Calif.)

Intraperitoneal injections of guinea pig serum are more effective in inhibiting growth of the solid form of the Murphy-Sturm lymphosarcoma carried in Wistar rats when there is a latent period of at least 5 days. Disparities between two groups of animals that have shorter and longer latent periods, respectively, are manifested by differences in: (a) the number of tumors that are completely inhibited, (b) the length of the latent period, and/or (c) the number of tumor regressions.

Intraperitoneal injections of guinea pig serum are shown to be effective in inhibiting growth of the more virulent ascites form of this tumor.

* Supported in part by Mr. and Mrs. John J. Elmore and the University of Southern California, Department of Medicine. We are indebted to the Hancock Foundation for laboratory space and facilities.

{dagger} Present address: Department of Chemistry, California Institute of Technology, Pasadena, California.

Received 4/11/58.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.